FDA OKs First Gene Therapy Implant for a Rare Eye Disease
The FDA has approved a new gene therapy for macular telangiectasia type 2 (MacTel), a rare eye disease that causes vision loss.
WebMD Health News
source https://www.medscape.com/s/viewarticle/fda-oks-first-gene-therapy-implant-rare-eye-disease-2025a10005r0?src=rss
WebMD Health News
source https://www.medscape.com/s/viewarticle/fda-oks-first-gene-therapy-implant-rare-eye-disease-2025a10005r0?src=rss
Comments
Post a Comment